Diastolic Dysfunction and COPD Exacerbation

References

• . Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442
   PubMed Web of Science ®Google Scholar
• . Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002;121( 5 suppl): 121S–126S
   PubMed Web of Science ®Google Scholar
• . Voelkel NF, Tuder R. COPD: exacerbation. Chest. 2000;117(5 suppl 2):376S–379S
   PubMedGoogle Scholar
• . Rabe KF, Hurd S, Anzueto A, . Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555
   PubMed Web of Science ®Google Scholar
• . Vestbo J. Clinical assessment, staging, and epidemiology of chronic obstructive pulmonary disease exacerbations. Proc Am Thorac Soc. 2006;3(3):252–256
   PubMedGoogle Scholar
• . Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 pt 1):1418–1422
   PubMed Web of Science ®Google Scholar
• . Dusser D. Chronic obstructive pulmonary disease exacerbations and their impact on the long-term natural history of the disease [in French]. Presse Med. 2008;37(11):1599–1603
   PubMedGoogle Scholar
• . Calverley PM, Anderson JA, Celli B, ; TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;22;356(8):775–789
   Google Scholar
• . Tashkin DP, Celli B, Senn S, ; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;9;359(15):1543–1554
   Google Scholar
• . Aurigemma GP, Gaasch WH. Clinical practice. Diastolic heart failure. N Engl J Med. 2004;351(11):1097–1105
   PubMedGoogle Scholar
• . Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation. 2000;101(17):2118–2121
   PubMed Web of Science ®Google Scholar
• . Le Jemtel TH, Padeletti M, Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol. 2007;49(2):171–180
   PubMed Web of Science ®Google Scholar
• . Galderisi M. Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects. Cardiovasc Ultrasound. 2005;3:9
   PubMedGoogle Scholar
• . Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol. 1997;30(6):1527–1533
   PubMed Web of Science ®Google Scholar
• . Nishimura RA, Tajik J. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol. 1997;30(1):8–18
   PubMed Web of Science ®Google Scholar
• . Ommen SR, Nishimura RA, Appleton CP, . Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler catheterization study. Circulation. 2000;102(15):1788–1794
   PubMed Web of Science ®Google Scholar
• . Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GKM, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196–204
   PubMed Web of Science ®Google Scholar
• . Chabot F, Gomez E, Guillaumot A, Kheir A, Chaouat A. Acute exacerbations of chronic obstructive pulmonary disease [in French]. Presse Med. 2009;38(3):495–495
   Google Scholar
• . Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respir Care. 2003;48(12):1204–1213
   PubMedGoogle Scholar
• . Miravitlles M, Guerrero T, Mayordomo C, Sánchez-Agudo L, Nicolau F, Segú JL. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group. Respiration. 2000;67(5):495–501
   PubMed Web of Science ®Google Scholar
• . Restrepo RD, Alvarez MT, Wittnebel LD, . Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3(3):371–384
   PubMedGoogle Scholar
• . Feifer RA, Aubert R, Verbrugge RR, Khalid M. Disease management. 2002;5(3):143–156
   Google Scholar
• . Barnes PJ. Future treatments for chronic obstructive pulmonary disease and its comorbidities. Proc Am Thorac Soc. 2008;5(8):857–864
   PubMedGoogle Scholar
• . Caruana L, Petrie MC, Davie AP, McMurray JJ. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from “diastolic heart failure” or from misdiagnosis? A prospective descriptive study. BMJ. 2000;321(7255):215–218
   PubMedGoogle Scholar
• . Curkendall SM, DeLuise C, Jones JK, . Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol. 2006;16(1):63–70
   PubMed Web of Science ®Google Scholar
• . Rutten FH, Cramer MJ, Grobbee DE, . Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J. 2005;26(18):1887–1894
   PubMed Web of Science ®Google Scholar
• . Tutar E, Kaya A, Gülec S, . Echocardiographic evaluation of left ventricular diastolic function in chronic cor pulmonale. Am J Cardiol. 1999;83(9):1414–1417
   PubMedGoogle Scholar
• . Boussuges A, Pinet C, Molenat F, . Left atrial and ventricular filling in chronic obstructive pulmonary disease. An echocardiographic and Doppler study. Am J Respir Crit Care Med. 2000;162(2 pt 1):670–675
   PubMedGoogle Scholar
• . Schena M, Clini E, Errera D, Quadri A. Echo-Doppler evaluation of left ventricular impairment in chronic cor pulmonale. Chest. 1996;109(6):1446–1451
   PubMedGoogle Scholar
• . Enriquez-Sarano M, Rossi A, Seward JB, Bailey KR, Tajik AJ. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol. 1997;29(1):153–159
   PubMedGoogle Scholar
• . Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107(11):1514–1519
   PubMed Web of Science ®Google Scholar
• . Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–1257
   PubMed Web of Science ®Google Scholar
• . Steele P, Ellis JH, Van Dyke D, Sutton F, Creagh E, Davies H. Left ventricular ejection fraction in severe chronic obstructive airways disease. Am J Med. 1975;59(1):21–28
   PubMedGoogle Scholar